SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Equities researchers at Scotiabank lifted their FY2026 earnings per share estimates for shares of SNC-Lavalin Group in a note issued to investors on Thursday, October 22nd. Scotiabank analyst J. Goldman now expects that the company will post earnings per share of $3.93 for the year, up from their previous forecast of $3.85. Scotiabank also issued estimates for SNC-Lavalin Group’s FY2027 earnings at $4.48 EPS.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.
Read More
- Five stocks we like better than SNC-Lavalin Group
- Microsoft’s Earnings Problem: Even Great May Not Be Enough
- 3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
